Inflammatory Bowel Disease Research Registry
NCT00574028 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 138
Last updated 2014-12-10
Summary
The objective and aims of this study is to develop The University of California Irvine Medical Center Inflammatory Bowel Disease Research Registry for the purpose of:
1. Performance of retrospective studies on inflammatory bowel disease to assess disease outcomes and response to therapy.
2. Obtaining permission from the Research Registry participants to be contacted by members of The University of California Irvine Medical Center Inflammatory Bowel Disease Research Center to identify patients that may be eligible for participation in future research studies.
3. Performance of studies to quantify disease phenotypes and treatment patterns.
Conditions
Sponsors & Collaborators
-
University of California, Irvine
lead OTHER
Principal Investigators
-
Nimisha K Parekh, M.D. · University of California, Irvine
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-08-31
- Primary Completion
- 2014-04-30
- Completion
- 2014-04-30
Countries
- United States
Study Locations
More Related Trials
-
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
NCT02054533 ·Status: COMPLETED
-
Value of Fecal Calprotectin
NCT00577928 ·Status: COMPLETED
-
Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease
NCT05733845 ·Status: RECRUITING ·Phase: NA
-
Exacerbating Factors in Inflammatory Bowel Disease
NCT01405105 ·Status: COMPLETED
-
Registry and Biorepository for IBD in Central Texas
NCT04617184 ·Status: RECRUITING
-
Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel Disease
NCT03239704 ·Status: UNKNOWN ·Phase: NA
-
Genetic Studies of Inflammatory Bowel Disease
NCT00340444 ·Status: COMPLETED
-
Comparing the Accuracy of Different Ultrasound-based Scores to Assess Disease Severity in Patients with Inflammatory Bowel Disease
NCT06705972 ·Status: NOT_YET_RECRUITING
-
Robotic Inflammatory Bowel Disease Development, Learning and Efficacy Study
NCT06579443 ·Status: RECRUITING
-
Gene Expression in Inflammatory Bowel Disease
NCT01171872 ·Status: ENROLLING_BY_INVITATION
-
Phenotypic Characteristics of Inflammatory Bowel Disease in Southeast Asian Population - A Multi-centered US Study
NCT00573846 ·Status: WITHDRAWN
-
Airway Involvement In Inflammatory Bowel Disease
NCT06090045 ·Status: NOT_YET_RECRUITING
-
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
NCT02791854 ·Status: ENROLLING_BY_INVITATION
-
Ocular Manifestations of Inflammatory Bowel Disease
NCT04771039 ·Status: COMPLETED
-
Renal Involvement in Adult Patients with Inflammatory Bowel Disease and Its Relation to Duration and Disease Activity
NCT06717516 ·Status: NOT_YET_RECRUITING
-
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
NCT03251118 ·Status: ACTIVE_NOT_RECRUITING
-
Interactions Between Immune Cells of Intestinal Mucosa or Peripheral Blood With the Extracellular Matrix in Inflammatory Bowel Disease (IBD)
NCT00915044 ·Status: UNKNOWN
-
Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants.
NCT07172945 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Occupational Insertion and Educational Level of Adult Patients With Pediatric Early Inflammatory Bowel Disease (IBD)
NCT04887428 ·Status: COMPLETED
-
Prevalence of Lymphoma in IBD
NCT00577538 ·Status: COMPLETED
-
Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
NCT06655415 ·Status: RECRUITING
-
Paricipant Preferences in the Treatment of Inflammatory Bowel Disease (IBD) in Europe
NCT04597905 ·Status: COMPLETED
-
Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease
NCT05598489 ·Status: UNKNOWN
-
Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry
NCT00833170 ·Status: COMPLETED
-
Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases
NCT02508012 ·Status: COMPLETED ·Phase: NA